Literature DB >> 16720920

Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer.

Yasunori Hashiguchi1, Hiroshi Tsuda, Christina A Bandera, Sadako Nishimura, Takeshi Inoue, Naoki Kawamura, Ross S Berkowitz, Samuel C Mok.   

Abstract

This study compared the DNA, RNA, and protein levels of osteopontin (OPN) in endometrioid endometrial cancer (EEC) and ovarian endometrioid cancer (OEC). In total, 63 cancer cases (EEC: 33, OEC: 30) were included. Of these, 47 (EEC: 26, OEC: 21) were examined by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and 48 (EEC: 25, OEC: 23) were examined by quantitative PCR. OPN expression was detected in 15 (50.0%) of 30 EECs and in 14 (50.0%) of 28 OECs. There was no significant difference in the percentage of positive cytoplasmic OPN staining between the EECs and OECs (12.8 vs 10.4; p = 0.6811). The correlation between relative mRNA and protein expression levels was significant in both the EECs and OECs; however, the correlation between relative DNA and mRNA levels was not significant. There was no significant difference in OPN expression between the EECs and OECs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720920     DOI: 10.1385/MO:23:2:205

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  12 in total

1.  ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer.

Authors:  A G Casson; S M Wilson; J A McCart; F P O'Malley; H Ozcelik; M S Tsao; A F Chambers
Journal:  Int J Cancer       Date:  1997-09-04       Impact factor: 7.396

2.  Differential osteopontin expression in lung cancer.

Authors:  J Zhang; K Takahashi; F Takahashi; K Shimizu; F Ohshita; Y Kameda; K Maeda; K Nishio; Y Fukuchi
Journal:  Cancer Lett       Date:  2001-10-10       Impact factor: 8.679

3.  Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Authors:  Jae-Hoon Kim; Steven J Skates; Toshimitsu Uede; Kwong-kwok Wong; John O Schorge; Colleen M Feltmate; Ross S Berkowitz; Daniel W Cramer; Samuel C Mok
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

4.  Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo.

Authors:  H C Crawford; L M Matrisian; L Liaw
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

5.  Osteopontin expression in ovarian carcinomas and tumors of low malignant potential (LMP).

Authors:  D G Tiniakos; H Yu; H Liapis
Journal:  Hum Pathol       Date:  1998-11       Impact factor: 3.466

6.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

7.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

Authors:  G F Weber; S Ashkar; M J Glimcher; H Cantor
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

8.  Five-year survival in patients with endometrioid carcinoma of the ovary versus those with serous carcinoma.

Authors:  J Zwart; J P Geisler; H E Geisler
Journal:  Eur J Gynaecol Oncol       Date:  1998       Impact factor: 0.196

9.  The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.

Authors:  L Liaw; M P Skinner; E W Raines; R Ross; D A Cheresh; S M Schwartz; C M Giachelli
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

Authors:  Philip S Rudland; Angela Platt-Higgins; Mohamed El-Tanani; Suzete De Silva Rudland; Roger Barraclough; John H R Winstanley; Rachel Howitt; Christopher R West
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  4 in total

1.  Clinical significance of osteopontin expression in cervical cancer.

Authors:  HanByoul Cho; Soon Won Hong; Youn Jin Oh; Min A Kim; Eun Suk Kang; Jong Min Lee; Sang Wun Kim; Sung Hoon Kim; Jae Hoon Kim; Young Tae Kim; Kook Lee
Journal:  J Cancer Res Clin Oncol       Date:  2008-01-22       Impact factor: 4.553

2.  Regulatory role of osteopontin in malignant transformation of endometrial cancer.

Authors:  Sabarish Ramachandran; Kun-Young Kwon; So-Jin Shin; Sang-Hoon Kwon; Soon-Do Cha; Hyun-Gyo Lee; Young-Bin Hong; Insoo Bae; Gun-Ho Lee; Chi-Heum Cho
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

3.  Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.

Authors:  Yulan Liu; Hongbo Lei; Jixiang Zhang; Jun Wang; Kui Li; Weiguo Dong
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

4.  Correlation between ovarian neoplasm and serum levels of osteopontin: a meta-analysis.

Authors:  Yue-Dong Wang; He Chen; Hui-Qiag Liu; Min Hao
Journal:  Tumour Biol       Date:  2014-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.